WNT4 rs7961894: Genetics, Bone Density, and Reproduction
The rs7961894 single nucleotide polymorphism is an intronic genetic variant located within the WNT4 gene on chromosome 1. Genome-wide association research links this variant to subtle differences in complex polygenic traits, including peak bone mineral density, timing of menarche, and reproductive span. Because this common variant exhibits modest statistical effects rather than deterministic outcomes, evidence for direct clinical utility remains limited.
What each genotype means
Common genetic profile
This genotype represents the most frequently observed sequence at this location in many populations. Research into this variant has explored its potential links to complex traits like bone mineral density and reproductive timing, but these associations are generally considered to have limited evidence and small individual effects. This result does not provide a medical diagnosis or a specific health prediction.
This is the most common genotype in many global populations, though exact frequencies vary significantly by ancestry.
Common genetic profile
This genotype represents a heterozygous state where one copy of the variant is present. While this variant has been studied for potential associations with traits such as bone mineral density and reproductive span, the evidence remains limited and the clinical significance is not well-established. This information is for educational purposes and should not be used to guide medical decisions.
This genotype is found at varying frequencies globally, reflecting the common nature of both the C and T alleles in many human populations.
Common genetic profile
This genotype represents the homozygous state for the T allele at this position. Current scientific literature suggests this variant may be associated with variations in complex traits like bone mineral density and reproductive timing, but these findings are based on limited evidence and represent small statistical trends rather than definitive health outcomes. This result is not a diagnostic tool.
This genotype is observed across diverse populations, with its prevalence depending on the specific ancestral background of the individual.
Genomic Context and the WNT4 Gene
The single nucleotide polymorphism rs7961894 is located on human chromosome 1 in an intronic region of the WNT4 (Wnt family member 4) gene. The WNT4 locus provides crucial biological instructions for synthesizing a secreted signaling glycoprotein belonging to the evolutionarily conserved WNT signaling pathway. In mammalian development, WNT4 signaling is essential for the prenatal differentiation of the female reproductive system, including Müllerian duct development, ovarian follicle maintenance, and kidney organogenesis. While high-impact, rare mutations in WNT4 lead to severe developmental disorders such as Müllerian aplasia and hyperandrogenism or SERKAL syndrome, common non-coding variants like rs7961894 function very differently. Rather than destroying the protein's coding sequence, common polymorphisms in non-coding regions are thought to gently alter transcriptional regulation, chromatin accessibility, or alternative splicing levels.
Observed Associations: Bone Density and Reproductive Span
Through large-scale genome-wide association studies (GWAS), researchers have identified rs7961894 and related proxies in the 1p36 region as linked to variation in female reproductive biology and skeletal traits. The Wnt signaling cascade regulates osteoblast differentiation and bone formation alongside gonadal maturation. Consequently, association datasets curated in public repositories like the GWAS Catalog have correlated rs7961894 with differences in peak bone mineral density (BMD) across developmental cohorts, as well as timing of menarche and variation in female reproductive span. However, the scientific evidence for rs7961894 acting as an independent, high-impact clinical predictor remains limited. Each copy of the associated allele contributes a very small shift in trait variance, reflecting a polygenic architecture where hundreds of independent loci interact with lifestyle, nutrition, and environmental exposures.
Population Frequency and Ancestry Patterns
The rs7961894 variant is common across global human populations, exhibiting moderate differences in frequency depending on genetic ancestry. According to standard reference datasets such as the Genome Aggregation Database (gnomAD), the minor allele frequency is approximately 0.35 among individuals of European ancestry and reaches approximately 0.45 among individuals of East Asian ancestry. Because both alleles are widespread, carrying one or two copies of the minor allele is completely normal across human genomes. These broad frequency ranges also emphasize that the variant is an ancient, neutral-to-modest modifier within human evolutionary history rather than a deleterious, selected-against mutation.
Clinical Interpretation and Limitations
Discovering your rs7961894 genotype through personal genomic analysis provides scientific insight into the polygenic background that influences bone and endocrine health, but it cannot be used to diagnose any medical condition. Having a specific genotype does not mean you will develop low bone mineral density, experience early or late menarche, or encounter reproductive health disorders. Bone strength and reproductive timelines are primarily shaped by complex biological factors, diet, physical activity, hormonal balances, and overall medical care. Clinical assessments like dual-energy X-ray absorptiometry (DEXA) scans and routine gynecological evaluations remain the gold standard for clinical health monitoring.
How common is this variant?
The rs7961894 variant is widespread globally, with a minor allele frequency of approximately 0.35 in European populations and approximately 0.45 in East Asian populations in the gnomAD database.
Frequently asked questions
What is the rs7961894 variant in the WNT4 gene?
The rs7961894 variant is a common single nucleotide polymorphism located in an intronic non-coding region of the WNT4 gene on chromosome 1. It acts as a common genetic marker evaluated in population studies rather than a damaging structural mutation.
Does rs7961894 cause osteoporosis or bone fractures?
No, rs7961894 does not cause osteoporosis or ensure bone fractures. While genome-wide association studies connect it to subtle shifts in peak bone mineral density, bone health is governed by hundreds of genetic factors combined with diet, calcium intake, exercise, and hormonal health.
Can my rs7961894 genotype determine when menarche or menopause occurs?
No, this genetic variant cannot predict the exact timing of puberty, menarche, or menopause. Statistical studies show that common variants in the WNT4 pathway explain only a fractional difference in reproductive timing across large populations.
Is rs7961894 linked to severe WNT4 developmental disorders?
No. Rare monogenic syndromes such as Müllerian aplasia or SERKAL syndrome arise from severe coding sequence mutations that disrupt WNT4 protein synthesis. In contrast, rs7961894 is a benign, common intronic variation found in billions of healthy individuals.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7961894?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in WNT4
This regulatory variant in the WNT4 locus is a well-established genetic marker associated with susceptibility to endometriosis, though its effect size and significance vary across ethnic populations.
This variant in the WNT4 locus is significantly associated with the risk of endometriosis and influences reproductive tract development.
Missense mutations in WNT4 are associated with atypical Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome and disorders of sex development.
Common regulatory variant near WNT4 consistently associated with endometriosis risk and female reproductive tract morphology.
Non-coding regulatory variant in the WNT4 region associated with pelvic endometriosis, uterine fibroid risk, and Müllerian duct development.
Regulatory variant near WNT4 associated with risk of endometriosis and ovarian cancer, influencing reproductive hormone regulation.